These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 966573)

  • 1. [Ocular myasthenia caused by D-penicillamine (author's transl)].
    Schmidt D; Kommerell G
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):409-13. PubMed ID: 966573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D; Hopf HC; Janzen RW; Meyer W
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1153-8. PubMed ID: 976101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia (author's transl)].
    Blanloeil Y; Baron D; Gazeau MF; Nicolas F
    Anesth Analg (Paris); 1980; 37(7-8):441-3. PubMed ID: 7425327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis.
    Liu GT; Bienfang DC
    J Clin Neuroophthalmol; 1990 Sep; 10(3):201-5. PubMed ID: 2144538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
    Wysocka K; Fabian F; Listewnik M
    Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of malignant rheumatoid arthritis associated with myasthenia gravis by D-penicillamine treatment (author's transl)].
    Suzuki H; Imai H; Shiokawa Y
    Ryumachi; 1980 Jun; 20(3):163-70. PubMed ID: 7414431
    [No Abstract]   [Full Text] [Related]  

  • 9. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL; Mewis L; Stewart RH
    Ann Ophthalmol; 1981 Oct; 13(10):1171-2. PubMed ID: 7316342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Agranulocytosis and myasthenia gravis probably induced by D-penicillamine in rheumatoid patients (author's transl)].
    Hoshi K; Mizushima Y
    Ryumachi; 1981 May; 21(3):234-42. PubMed ID: 7313901
    [No Abstract]   [Full Text] [Related]  

  • 11. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
    Dubost JJ; Soubrier M; Bouchet F; Kemeny JL; Lhopitaux R; Bussière JL; Sauvezie B
    Rev Neurol (Paris); 1992; 148(3):207-11. PubMed ID: 1604135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis].
    Ongerboer de Visser BW; van Soesbergen RM
    Ned Tijdschr Geneeskd; 1978 Dec; 122(52):2055-8. PubMed ID: 732905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 15. D-penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Froelich CJ; Hashimoto F; Searles RP; Bankhurst AD
    J Rheumatol; 1979; 6(2):237-9. PubMed ID: 458795
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
    Bucknall RC
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):114-7. PubMed ID: 122656
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H; Job-Deslandre C; Delrieu F; Kahan A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):341-4. PubMed ID: 3738397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].
    Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI
    Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
    Kuriyama S; Hosoya T; Sakai O
    Ryumachi; 1991 Jun; 31(3):298-302; discussion 302-3. PubMed ID: 1948449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.